An interventional study of Web-Based Mind-Body Based Awareness Program in Infertility, Female, sponsored by Hacettepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 23 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Hacettepe University · Not applicable, Interventional, and Supportive care
The goal of this two-group parallel randomized controlled study is to determine the effect of a web-based mind-body-based awareness program based on Meleis Transition Theory on fertility awareness and readiness levels in women receiving infertility treatment.
Improving fertility awareness in women undergoing infertility treatment may facilitate changes in lifestyle behaviors that can enhance fertility. Increasing fertility awareness among infertile individuals may improve the likelihood of pregnancy and the chance of achieving a healthy pregnancy. It may also positively influence general health and reproductive health and support the modification of negative lifestyle behaviors that could affect the infertility treatment process. Fertility awareness may contribute to fertility readiness, which in turn may have a positive impact on treatment outcomes.
This study will be conducted as a two-group parallel randomized controlled trial to determine the effect of a web-based mind-body awareness program based on Meleis Transition Theory on fertility awareness and fertility readiness levels in women undergoing infertility treatment. The study will be carried out with women receiving infertility treatment at the In Vitro Fertilization Unit of Hacettepe University Faculty of Medicine.
The sample will consist of women who voluntarily agree to participate in the study, have initiated the infertility treatment process, have undergone a maximum of two IVF attempts, are able to speak and understand Turkish, have at least a primary school education, are not participating in any psychological or social support group, and have not completed or are not currently participating in any mind-body program related to fertility.
The sample size was determined in consultation with a statistician. Based on a review of the literature, particularly a study examining the effects of progressive muscle relaxation exercises on mental health and treatment outcomes in women undergoing IVF, a power analysis was conducted to determine the required sample size. The power analysis indicated that, for a power of 90%, a 95% confidence level, an effect size of f = 0.198, two groups (intervention and control), and three repeated measurements, a total sample size of 48 participants was required.
Considering the anticipated attrition resulting from the transition from chemical pregnancy to clinical pregnancy and the potential losses inherent in the IVF treatment process, the calculated sample size was inflated by 60%. Accordingly, the study sample was planned as 78 participants in total, with 39 in the intervention group and 39 in the control group. After randomization, no new participants will be added to replace those who withdraw or are excluded from the study for any reason.
The data collection instruments will include a Demographic Information Form, the Fertility Awareness Scale, and the Fertility Readiness Scale.
Within the scope of the study, a web-based mind-body awareness program based on Meleis Transition Theory will be applied to the women in the intervention group. The control group will receive routine nursing care provided in the unit.
The research data will be analyzed using mean, standard deviation, median, quartiles, percentages, minimum and maximum values, as well as Chi-square and Mann-Whitney U tests.
552 studies on the registry are indexed under Infertility, Female; 137 are open to participants now.
This study's planned enrollment of 78 is below the median of 100 across 378 interventional studies indexed under Infertility, Female.
Browse Infertility, Female studies →Hacettepe University is the lead sponsor of 1,007 studies on the registry; 214 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in the intervention group will participate in a web-based mind-body awareness program.
Other: Web-Based Mind-Body Based Awareness Program
No intervention will be applied to the control group.
The program was developed in accordance with peer-reviewed literature and expert opinions. A nursing approach based on Meleis Transition Theory will include education, mind-body awareness practices, and messages specific to women's health. Participants will take part in a five-session awareness program lasting approximately two weeks. Participants will be asked to complete their first final assessment one day after the oocyte pick-up (OPU) procedure, which corresponds to approximately 8-12 days after ovarian stimulation. No mind-body exercises will be requested between embryo transfer and the day of the pregnancy test. During this period, follow-up between the researcher and participants will continue, and nursing care based on Meleis' theory will be provided. The implementation phase of the study will be completed after the second final assessment conducted one day before the pregnancy test, with at least the minimum required sample size achieved.
Fertility Awareness Scale
This scale was developed to measure fertility awareness in women. The scale is Likert-type and has 19 items and two sub-dimensions (Body Awareness, Cognitive Awareness). Items in the scale are scored from 1 to 5 (1-Never, 2-Rarely, 3-Occasionally, 4-Most of the time and 5-Always) and there are no reverse-scored items. Possible scores in total for the scale are 19-95, 10-50 for the "Body Awareness" sub-dimension, and 9-45 for the "Cognitive Awareness" sub-dimension. If the total score is between 19-43, the awareness level is interpreted as ''low'', if it is between 44-69, it is ''medium'', and if it is between 70-95, it is interpreted as ''high''.
Time frame: A pre-test will be administered before the study begins. Then, an interim test will be administered 1 day after the OPU procedure, followed by a final test one day before the pregnancy test.
Fertility Preparedness Scale for Women Receiving Fertility Treatment
The scale, consisting of 23 questions, was created to measure the readiness of women preparing to become pregnant. The scale consists of 3 sub-dimensions: "hope and awareness", "relaxed body and brain" and "positive feelings and thoughts". Since the scale items consist only of positive expressions, the scores obtained are calculated as they are. The scores of the items are 5, 4, 3, 2, and 1, respectively. The minimum score is 23, the maximum score is 115 on the scale, and a high score indicates that fertility preparedness is strong. The median score on the scale is 56. A score of 56 or higher on the scale indicates that the woman feels more prepared for pregnancy, while a lower score indicates that she feels less prepared.
Time frame: A pretest will be administered before the study begins. Then, an interim test will be administered 1 day after the OPU procedure, followed by a final test to be conducted one day before the pregnancy test.
Introductory Information Form
Follicle-stimulating hormone (FSH) and estradiol (E2) levels, number of oocytes collected, embryo transfer status, and blood pregnancy test results will be taken from the patient file and added to the form.
Time frame: FSH and E2 levels will be monitored on the 2nd-3rd day of the menstrual cycle, the number of oocytes collected on the 16th day of the cycle, embryo transfer status on the 18th day of the cycle, and pregnancy test on the 28th day of the cycle.
Plan to share: No
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.